meropenem
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
21 FDA-registered drug labelers
ACS Dobfar S.p.A
Amneal Pharmaceuticals LLC
ARMAS PHARMACEUTICALS INC
B. Braun Medical Inc.
BluePoint Laboratories
BROOKS STERISCIENCE LIMITED
Civica, Inc
Eugia US LLC
Fresenius Kabi USA, LLC
Gland Pharma Limited
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Melinta Therapeutics, LLC
Qilu Antibiotics Pharmaceutical Co., Ltd.
Sagent Pharmaceuticals
Sandoz Inc
Savior Lifetec Corporation
Shandong Anhong Pharmaceutical Co., Ltd.
Sumitomo Pharma Co., Ltd.
WG Critical Care, LLC
Xellia Pharmaceuticals USA LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Meropenem
- •Meropenem and Sodium Chloride
- •Vabomere
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS96036-03-2
PubChem CID441130
DTXSIDDTXSID7045526
FormulaC17H25N3O5S
Mol. Weight383.5 g/mol
SMILESCC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O
Data Sources
4411302026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/meropenem/cids/JSON
Archive: data/sources/pubchem_name/meropenem.json
CAS 96036-03-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json